Clinical Trial Update: Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a conditioning regimen with post-transplant GVHD prophylaxis using cyclophosphamide and methotrexate in patients eligible for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Hematologic Malignancy

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Nantes University Hospital | Conditions: Graft Versus Host Disease, Hematologic Malignancy | Phase 2 | Status: RECRUITING